DEFA14A ·Filed Apr 29, 2026

BAX

BAXTER INTERNATIONAL INC
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago SEC0001193125-26-189237
Proxy solicitation materials
Actionable Insight • Neutral

Monitor the shareholder vote outcome at the upcoming annual meeting; the proposal is likely to pass given board support and lack of known opposition. No trading action warranted based solely on this filing.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
BAX ▲ +32.54% at T+60d
NEUTRAL call ✓ call won +32.54% · α vs SPY +28.43% · entry $16.90 → $22.40
Entry anchored
Apr 28, 03:59 PM ET
via exchange tick
T+1d
+4.02%
call +4.02% · α +3.00%
$17.58
settled 5mo ago
T+5d
-0.89%
call -0.89% · α -4.00%
$16.75
settled 5mo ago
T+20d
+14.38%
call +14.38% · α +8.92%
$19.33
settled 4mo ago
T+60d
+32.54%
call +32.54% · α +28.43%
$22.40
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Baxter International filed additional definitive proxy materials (DEFA14A) urging stockholders to vote FOR a proposed charter amendment to reduce the minimum board size from nine to seven directors and eliminate the maximum, with a related bylaw amendment fixing board size between 7 and 12. The board recommends approval to enhance flexibility and board refreshment. This is a routine governance proposal with no immediate financial impact.

Key Facts

  • Proposal to amend certificate of incorporation to reduce minimum directors from 9 to 7 and eliminate maximum
  • Board adopted bylaw amendment fixing board size range of 7 to 12, contingent on charter amendment approval
  • Board unanimously recommends vote FOR the proposed charter amendment
  • Annual meeting date not disclosed in this filing
  • Non-Executive Chair Brent Shafer signed the letter

Financial Impact

No direct financial impact; governance change only

Risk Factors

  • Potential shareholder opposition to governance changes could result in a close vote, but risk of failure appears low
  • No material financial or operational impact expected

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
23% bullish (22 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-189237
Document: 0001193125-26-189237-index-headers.html0001193125-26-189237
Document: 0001193125-26-189237-index.html0001193125-26-189237
Document: 0001193125-26-189237.txt0001193125-26-189237
12 reports for BAX
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+5▲ +5.37%Jun 11, 2026
Filters
Rows
Reports for BAX — sortable, filterable
TypeNow
Aug 19, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$26.64 $23.02▼ −13.59%▼ −11.64%$23.51 (−11.75%)
Aug 18, 2026
6w ago
8-K
MIXED ★ 5/10
$26.64 $23.02▼ −13.59%▼ −11.64%$23.51 (−11.75%)
Aug 12, 2026
7w ago
Institutional Cluster
BULLISH ★ 4/10
$26.95 $24.18▼ −10.28%▼ −8.38%$23.51 (−12.76%)
Aug 4, 2026
8w ago
8-K
NEUTRAL ★ 4/10
$28.35 $25.48▼ −10.12%▼ −8.89%$23.51 (−17.07%)
Jul 30, 2026
9w ago
8-K
BULLISH ★ 7/10
$26.75 $25.93▼ −3.07%▼ −7.03%$23.51 (−12.11%)
Jun 11, 2026
16w ago
Institutional Cluster
BEARISH ★ 6/10
$20.49 $22.46▼ −9.61%▼ −7.72%$23.51 (−14.74%)
May 8, 2026
20w ago
8-K
NEUTRAL ★ 2/10
$17.53 $20.03▲ +14.26%▲ +14.57%$23.51 (+34.11%)
Apr 30, 2026
22w ago
8-K
MIXED ★ 5/10
$17.58 $19.25▲ +9.50%▲ +4.53%$23.51 (+33.73%)
Apr 29, 2026
22w ago
DEFA14A
NEUTRAL ★ 2/10
$16.90 $19.33▲ +14.38%▲ +8.92%$23.51 (+39.11%)
Mar 23, 2026
27w ago
DEFA14A
NEUTRAL ★ 2/10
$16.61 $18.49▲ +11.32%▲ +3.90%$23.51 (+41.54%)
Showing 10 of 12

US Market Status

Market Open — Closes in 18m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access